Ashoka Mukpo, the NBC News freelance cameraman, who was on assignment with Dr. Nancy Snyderman in Liberia, is now being treated with the experimental antiviral drug, Brincidofovir, at the Nebraska Medical Center, the hospital reported Tuesday.
“After looking at the data on this drug, collaborating with the CDC and FDA and speaking with the patient and his family, we decided this was currently our best option for treatment,” said Phil Smith, M.D., medical director of the Biocontainment Unit. “Every patient is somewhat different, and we believe Brincidofovir is the best choice.”
Brincidofovir, manufactured by Chimirex in Durham, NC, is also being used to threat Dallas Ebola patient, Thomas Eric Duncan.
Dr. Mitchell Levy, Ashoka Mukpo’s father says his son is experiencing the type of symptoms expected from Ebola–“He’s experiencing some vomiting and diarrhea. These symptoms are exactly what’s to be expected at this stage of the disease.”
In Maryland, the National Institutes of Health (NIH) said that the unnamed patient exposed to Ebola in Sierra Leone last month has been released. For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page
2 thoughts on “Ashoka Mukpo receives Brincidofovir at Nebraska, NIH releases exposed patient”